Fingerprint
Dive into the research topics of 'A phase i trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: A Pediatric Brain Tumor Consortium (PBTC) study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically